Epstein-Barr virus Latent Membrane Protein 2A (LMP2A) is expressed in EBV-infected B cells in the germinal center, a site of significant apoptosis induced by engagement of Fas on activated B cells. Signals from the B cell receptor (BCR) protect germinal center B cells from Fas-mediated apoptosis, and since LMP2A is a BCR mimic, we hypothesized that LMP2A would also protect B cells from Fas-mediated apoptosis. Surprisingly, latently-infected human and murine B cell lines expressing LMP2A were more sensitive to Fas-mediated apoptosis, as determined by increases in Annexin-V staining, and cleavage of caspase-8, −3 and PARP. Additional studies show that LMP2A-expressing B cell lines demonstrate a Lyn- and Syk-dependent increase in sensitivity to Fas-mediated apoptosis, due to an LMP2A-dependent enhancement in Fas expression. These findings demonstrate the ability for LMP2A to directly increase a pro-apoptotic molecule and have implications for EBV latency as well as the treatment of EBV-associated malignancies.
Latent Membrane Protein 2A (LMP2A) of Epstein-Barr virus (EBV) protects B cells from many pro-apoptotic signals. LMP2A is expressed in EBV-infected B cells in the germinal center, which is a site of significant Fas-mediated apoptosis. Given that B cell receptor (BCR) stimulation protects B cells from Fas-mediated apoptosis and since LMP2A acts as a BCR mimic, we hypothesized that LMP2A would protect B cells from Fas-induced apoptosis. To test this hypothesis, LMP2A-negative and -positive B cell lines were exposed to a Fas-specific monoclonal antibody and apoptosis was assessed by Annexin V staining and PARP cleavage. Surprisingly, LMP2A-expressing B cell lines demonstrate an increased sensitivity to Fas-mediated apoptosis, due to a LMP2A-dependent enhancement in Fas expression. B cell lines harboring LMP2A mutations in either the Lyn or Syk binding site do not show an LMP2A-dependent increase in Fas levels and/or Fas-mediated apoptosis, indicating that LMP2A requires these two kinases to mediate these pro-apoptotic effects. Furthermore, experiments demonstrate that LMP2A enhances Fas-mediated apoptosis in human B cell lines in the presence of additional EBV latency proteins, indicating that LMP2A promotes Fas-dependent apoptosis in the natural context of the virus. These findings are the first to demonstrate a pro-apoptotic function of LMP2A and have implications for both EBV latency and EBV-associated malignancies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.